# Implementation Assessment: Is YaoBi-Skill “Perfect”?

## Short answer

No software in this domain should be called clinically “perfect”. The current repository is a strong lightweight MVP for research, teaching, rule explanation, and guided case generation, but it is not a validated clinical product and must not be used for autonomous diagnosis or prescribing.

## What is implemented well

- Rule-first architecture: deterministic YAML rules drive syndrome scoring, formula-route signals, module hits, conflict checks, and safety checks.
- Evidence traceability: normalized tags, rule hits, formula routes, modules, and reports preserve evidence tags or source fields.
- CaseGuide workflow: `CaseGuideSession` implements a staged intake flow with consent, red flags, basic information, pain profile, neuro-orthopedic screening, TCM inquiry, Shen-rule signal detection, comorbidity/medication capture, dynamic repair, case summary, and final report.
- Safety boundary: red flags stop or caution the flow; diagnosis and prescription requests are routed to clinician-review hypotheses and non-prescriptive formula/module explanations.
- Test coverage: tests cover consent privacy, urgent red flags, guided case completion, adaptive planning, rule pipeline outputs, and safety disclaimers.

## What is intentionally not implemented as clinical automation

- Final clinical diagnosis.
- Complete patient-executable prescriptions.
- Dose instructions for self-use.
- Replacement of doctor review, physical examination, imaging interpretation, or lab review.

## Remaining gaps before production use

1. Expert calibration: rule weights and thresholds need review against curated沈钦荣腰痹 cases and expert annotations.
2. Stronger extraction: current text extraction is intentionally lightweight; production should add robust schema validation and human correction UI.
3. Frontend implementation: the repo defines UI protocol but does not yet implement React/Next.js pages.
4. API service: FastAPI endpoint stubs are exported, but an HTTP service with auth, persistence, audit logs, and upload handling is not yet built.
5. LLM serving: Dao1 integration is a safe placeholder; production needs vLLM/Transformers wiring, prompt tests, output guards, and license compliance review.
6. Clinical safety validation: red-flag recall, forbidden-output rate, toxic-herb warning rate, and expert review metrics must be evaluated offline before real-world deployment.
7. Privacy/compliance: de-identification is regex-based and should be expanded before handling real patient data.

## Current maturity verdict

The project is now a coherent **lightweight Skill + Hermes-style agent MVP**. It is suitable for code review, demo, research prototyping, and expert feedback. It is not yet a clinically validated or production-ready medical system.
